Assessing the effect of Diclofenac suppository on post-operative pain of Mastectomy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210505051191N1

Enrollment

Registered

2021-06-01

Start date

2019-12-22

Completion date

Unknown

Last updated

2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The effectiveness of Diclofenac suppository.

Interventions

Intervention group: Diclofenac suppository, 100 mg, after the surgery.

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Informed consent Age 18 years old and more The patient it candidate for Mastectomy

Exclusion criteria

Exclusion criteria: The patients disappointment

Design outcomes

Primary

Measure	Time frame
The amount of pain after Mastectomy. Timepoint: Immediately after surgery and 10 oclock at night. Method of measurement: Visual Analogue Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyedeh Fatemeh Amirkhalili

Islamic Azad University

www.naghiii.sss.1994@gmail.com+98 23 3239 2661

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026